Seattle Genetics, Inc. (SGEN) Offers A Good Entry Point Here

The price of Seattle Genetics, Inc. (NASDAQ:SGEN) stock ended February 10, 2020 trading at $116.51 which saw downtrend of 1.97% since the beginning of 2020. For most investors, the -0.77% rally in the share price could have prompted them to sell the stock, but doing that would be a mistake as it would be taking into consideration only the short-term performance of the stock.

A look at the SGEN stock today shows that it has gained 79.19% of its value over the past one year, which has led to some investors becoming excited about the short-term performance of Seattle Genetics, Inc. (NASDAQ:SGEN). If we turn to the stock analysts in general, they revealed that most of them are still bullish about the chances of the shares. The consensus rating from analysts for Seattle Genetics, Inc. (SGEN) is 2.2 which is a ,neutral rating. Over the past week, the stock has been rated as a Buy 9 times while it has been rated as a Hold 7 times. The 52-week high price for SGEN is $122.36 which is attained on November 25 while its 52-week low currently stands at $62.9 and was reached on May 15. At the moment, the stock is trading $4.91 above its YTD moving average set at $111.6.

Moving on, Seattle Genetics, Inc. (SGEN) last released its earnings for the December 2020 quarter of the fiscal year. The company performed lower over the past three months, with its earnings down -69% year-over-year at $-0.22. The company brought a surprise of -51 as analysts were predicting $-0.45 per share. The revenue generated by Seattle Genetics, Inc. in the December 2020 quarter surged by 66% to reach $289.8 million. This is high compared to the $174.51 million it recorded in the same quarter last year. To see what traders should watch in its March 2020 financial results, analysts have consensus earnings per share of $-0.34 which is lower than the $-0.32 recorded in the same quarter a year ago. Over the next 12 months, the earnings per share are expected to move by 168.7%. If it achieves that, then the company firmly believes that its long-term annual earnings growth rate target set at 23 % could be achieved. The company has also recorded a revenue of $801.4 million over the past 12 months.

In order to determine if the stock is worthy of your patience, you should know that Seattle Genetics, Inc. (NASDAQ:SGEN) is now trading at 0X the earnings per share recorded over the past 12 months. This is a downtrend compared to the readings of the sector which is 32.6X while the industry average stands at 23.38X. The most popular way to value a stock is to look at its historic Price-to-Earnings (P/E) ratio with the help of its earnings report over the past 12 months. Seattle Genetics, Inc. was able to achieve an EPS of $-1.87 during the last four quarters. The P/E ratio is widely known due to the fact that it is widely used, simple, effective, and, tautologically.

On Monday, February 10 of 2020, the 14-day Absolute ATR (Average True Range) for SGEN moved by $3.98. Over the past seven days, the stock’s average daily volatility stood at 4.29%. A stock with a low volatility is usually a good one as it means that investors are very confident in the stock. Seattle Genetics, Inc.’s trading volume has recently moved to 1.33 million, which is compared with the average daily volume of 1.13 million shares.

The daily chart for SGEN, points out that the company has recorded 51.55% gains over the past six months. However, it is still 85.23% higher than its most recent low trading price. The performance of the stock over the past five days shows that it is up 7.2% though it is 4.67% above its three-week moving average. It is worthy to know that price action is not always clear. There are times when a stock will undergo some negatives, trade erratically within some range or even act very unpredictable. When that happens, then making use of moving averages makes the pattern clearer for traders. Comparing to 50-day SMA, the price of the stock has surged by 2.71% while it is up 33.06% against the 200-day SMA. This is usually seen as the last support line for a stock, as a move downward could signal a bearish trend or market. The daily chart of SGEN reveals that it has gained some grounds as it ended Monday with a 4.18% rise over the past 30 days.